Page 4 - Daniel Altmann News Today

A new report suggests that the Pfizer-BioNTech vaccine is effective against the new, more contagious strains of COVID from the U.K. and South Africa.

| UPDATED: 17:30, Fri, Jan 8, 2021 Link copied Sign up for FREE health tips to live a long and happy life SUBSCRIBE Invalid email When you subscribe we will use the information you provide to send you these newsletters. Sometimes theyll include recommendations for other related newsletters or services we offer. Our Privacy Notice explains more about how we use your data, and your rights. You can unsubscribe at any time. The UK and South African COVID-19 variants have been found to share a c...

Having one of the new coronavirus vaccines does not mean Britons, including pensioners, can act with wild abandon and go off to the bingo halls, the Deputy chief medical officer has said.    Professor Jonathan Van-Tam was asked at Wednesdays Downing Street press conference whether people who have had two doses of a vaccine would still have to follow strict rules such as not seeing their families. The scientist defined the question as whether its OK to behave with wild abandon and go off to t...

The approval of the Oxford-AstraZeneca vaccine has been hailed as a “game-changer” and a “triumphant moment” in the battle against coronavirus. One of the key people behind the new jab said it will provide some respite in the “blizzard” of the pandemic, and hope for the future. Professor Andrew Pollard, director of the Oxford Vaccine Group and chief investigator of the Oxford Vaccine Trial, said the development and approval of the vaccine is “an absolute triumph of academic collab...

The approval of the Oxford-AstraZeneca vaccine has been hailed as a “game-changer” and a “triumphant moment” in the battle against coronavirus. One of the key people behind the new jab said it will provide some respite in the “blizzard” of the pandemic, and hope for the future. Professor Andrew Pollard, director of the Oxford Vaccine Group and chief investigator of the Oxford Vaccine Trial, said the development and approval of the vaccine is “an absolute triumph of academic collab...

The approval of the Oxford-AstraZeneca vaccine has been hailed as a “game-changer” and a “triumphant moment” in the battle against coronavirus. One of the key people behind the new jab said it will provide some respite in the “blizzard” of the pandemic, and hope for the future. Professor Andrew Pollard, director of the Oxford Vaccine Group and chief investigator of the Oxford Vaccine Trial, said the development and approval of the vaccine is “an absolute triumph of academic collab...

Posted on December 30th, 2020 Courtesy The Times (UK) Astrazeneca chief promises 2 million doses a week The Covid vaccine developed by Oxford University and the drugmaker Astrazeneca has been approved for use in Britain, with government advisers saying that a single shot could achieve 70 per cent protection. The jab was authorised by the Medicines and Healthcare Products Regulatory Agency (MHRA) this morning amid mounting concerns over the new fast-spreading coronavirus...

The approval of the Oxford-AstraZeneca vaccine has been hailed as a “game-changer” and a “triumphant moment” in the battle against coronavirus. One of the key people behind the new jab said it will provide some respite in the “blizzard” of the pandemic, and hope for the future. Professor Andrew Pollard, director of the Oxford Vaccine Group and chief investigator of the Oxford Vaccine Trial, said the development and approval of the vaccine is “an absolute triumph of academic collab...

The approval of the Oxford-AstraZeneca vaccine has been hailed as a “game-changer” in the battle against coronavirus. One of the biggest benefits of this vaccine is that it does not need to be stored at very cold temperatures, like the Pfizer jab - which would make "an enormous difference" according to one expert. Andrew Hayward, professor of infectious diseases epidemiology at University College London, and a member of the Government’s New and Emerging Respiratory Virus Threats Adv...

The approval of the Oxford-AstraZeneca vaccine has been hailed as a “game-changer” and a “triumphant moment” in the battle against coronavirus. One of the key people behind the new jab said it will provide some respite in the “blizzard” of the pandemic, and hope for the future. Professor Andrew Pollard, director of the Oxford Vaccine Group and chief investigator of the Oxford Vaccine Trial, said the development and approval of the vaccine is “an absolute triumph of academic collab...